Genomic sequence of avian paramyxovirus type 2 and uses thereof
AssigneesUniversity of Maryland, College Park, The United States of America, as represented by the Secretary, Department of Health and Human Services
InventorsSiba K. Samal, Peter L. Collins
Life of this patent
Estimating the term…
Abstract
In this application is described the complete genomic sequence of avian parmyxovirus type 2, strains Yucaipa, England, Kenya and Bangor. The sequences are useful for production of recombinant infective virus, a virus vector, for vaccine development and for therapeutic compositions.
Claims20
An isolated nucleic acid comprising a nucleic acid sequence set forth in any of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3 and SEQ ID NO:4, or a 200 nucleotide contiguous portion thereof.
A nucleic acid encoding an amino acid sequence chosen from the group consisting of SEQ ID NO:
- 37-68.
A recombinant AMPV-2 virus or derivative thereof, having a genome comprising a sequence set forth in any of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, and SEQ ID NO:4.
Dependencies are inferred from the claim text.